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A recently reported rapid potentiation of NMDA receptors by Group I metabotropic glutamate receptors (mGluRIs) via a Homer protein
link is distinct from the classical, relatively slow inhibitory G-protein-associated signaling triggered by mGluRI activation. The relation-
ship between these two mechanisms remains unknown. Here, we focused on the mGluRI-dependent modulation of NMDAR response in
hippocampal dentate gyrus granule cells and cerebellar granule cells of C57BL6-J mice and found that these two contrasting mechanisms
overlap competitively on the time scale from hundreds of milliseconds to seconds, with the net effect depending on the cell type. At a
shorter time interval (units of millisecond), the Homer-mediated signal from mGluRIs prevails, causing upregulation of NMDAR func-
tion, in both dentate gyrus granule cells and cerebellar granule cells. Our results shed light on the possible mechanisms of anti-
schizophrenia drugs that disrupt Homer-containing protein link.
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tors; NMDA receptors
Introduction
Neuronal metabotropic glutamate receptors Group I (mGluRIs)
are classically viewed as the modulators (predominantly augmen-
tative) of NMDA receptors (NMDARs); G-protein signaling cas-
cades are the transfer mechanism of this modulation (Rossi et al.,
1996; Kunishima et al., 2000; Pin and Acher, 2002). This signaling
mechanism can be interrupted by blocking various stages of the
G-protein cascade. Pertussis toxin (PeTX) acts as a blocker of Gi,
Go, and Gt proteins (Kost et al., 1999), enabling research of the
mGluRI-NMDAR interaction cleared from G-protein signaling
effects.
The second, more recently discovered, mechanism of
mGluRI-NMDAR crosstalk is signal transfer via the Homer pro-
teins. Homer protein family contains a C-terminal coiled-coil
dimerization domain (“long” Homers), except for Homer1a and
Ania-3 (“short” Homers), which lack this domain and, as a result,
are unable to perform a scaffolding role linking other proteins.
Homer proteins bind to the mGluRIs (Brakeman et al., 1997),
and to the proteins of the Shank family (Tu et al., 1999). The
Shank proteins, in turn, connect to NMDARs via the protein
PSD-95, establishing a direct molecular link between mGluRIs
and NMDARs (Bertaso et al., 2010). Overexpressed Homer1a
disrupts mGluRI-NMDAR protein connection by outcompeting
“long” Homers on the binding site of mGluRIs, thus providing an
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Significance Statement
Here we study modulation of NMDA receptors triggered by activation of metabotropic glutamate receptors Group I via two
distinct pathways: classical G-protein signaling system and newly discovered high-speed modulatory mechanism associated with
Homer-protein-containing direct molecular link. We found that these two contrasting mechanisms overlap competitively on the
time scale from hundreds of milliseconds to seconds, with the net effect depending on the cell type. We have also found that both
crosstalk mechanisms cause significant changes in synaptic strength and plasticity. Our results resolve an apparent discrepancy
between earlier studies that demonstrated contradictive effects of Homer-containing protein link disruption on NMDA receptor
signaling. On top of that, our data provide a plausible explanation for unclear action mechanisms of anti-schizophrenia drugs.
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experimental approach where the mGluRI-NMDAR modulation
signal can pass through cytoplasmic biochemical cascades only.
We have previously shown that, at a short time scale (low
milliseconds), mGluRI activation in cerebellar granule cells
(CGCs) potentiates NMDARs in intact cells but has no effect
when the Homer molecular interlink has been disrupted by
Homer1a overexpression (Sylantyev et al., 2013). An earlier
study, however, showed that at longer intervals (hundreds of
milliseconds to seconds), the activation of mGluRIs in CGCs
does not affect NMDARs when the Homer scaffold is intact, but
depresses NMDAR responses when the Homer-containing inter-
link is abolished, that is, mGluRI-NMDAR modulatory signal is
delivered exclusively through G-protein cascades (Bertaso et al.,
2010). In contrast, long-term NMDAR effects were repeatedly
shown to be potentiated by mGluRIs in experimental cell systems
(Xenopus oocytes) (Skeberdis et al., 2001) and in brain areas other
than the cerebellum, such as the subthalamic nucleus (Awad et
al., 2000) and hippocampus (Harvey and Collingridge, 1993;
Fitzjohn et al., 1996; Naie and Manahan-Vaughan, 2004).
It has been widely accepted that NMDAR hypofunction is one
of the key factors provoking schizophrenia development (Steullet
et al., 2016; Nakazawa et al., 2017). Another important element,
in which dysfunction is tightly associated with the propagation of
schizophrenia, are mGluRIs (Cleva and Olive, 2011). In particu-
lar, the inhibition of metabolic signaling delivered by G-proteins
has been implicated in propagating schizophrenia symptoms
(Chowdari et al., 2002; Williams et al., 2004). In turn, Homer1-
knock-out animals, in which a direct mGluRI-NMDAR link is
absent, exhibit a wide spectrum of abnormalities that are consis-
tent with schizophrenia symptoms (Szumlinski et al., 2005), thus
suggesting Homer as an actor preventing schizophrenia develop-
ment. However, anti-schizophrenia drugs, such as haloperidol
and clozapine, upregulate the synthesis of Homer1a protein,
which destroys the Homer-containing mGluRI-NMDAR link
(Polese et al., 2002).
Here, we aimed to resolve these apparent functional discrep-
ancies and to clarify the interaction of overlapping signals
delivered through (1) rapid Homer-mediated and (2) slower
G-protein-mediated pathways of mGluRI-NMDAR crosstalk.
We hypothesized that mGluRIs, when activated, could modulate
NMDARs simultaneously via the two pathways, Homer- and
G-protein-controlled. The pathway that prevails is dependent on
the time scale of activation: the fast Homer-transduced effect is
more prominent at short-term intervals after mGluRI activation,
whereas the slower, G-protein-delivered effect has an advantage
on long-term intervals. To test the hypothesis, we set out to in-
vestigate the mGluRI-NMDAR interaction in two distinct cell
types, where earlier studies demonstrated different long-term
effects of mGluRIs on NMDAR response: potentiation (in hip-
pocampal dentate gyrus granule cells, DGCs) (Naie and
Manahan-Vaughan, 2004) and suppression (in CGCs) (Bertaso
et al., 2010).
Materials and Methods
Generation of cell cultures
Obtaining cells. Cultures were generated from E17.5, C57BL6-J mice.
Pregnant mother was killed with cervical dislocation according to UK
Animals (Scientific Procedures) Act 1986 Schedule 1. Embryos were re-
moved by caesarean section and decapitated in Hanks Balanced Salt
Solution (Invitrogen, 14170 – 88) containing 5% penicillin-streptomycin
(Invitrogen, 15070 – 063) on ice. Skulls were removed and brain tissue
dissected under a light microscope where the cerebellum were separated
followed by hippocampi removal from the embryo forebrain. Tissue was
then exposed to enzymatic digestion using Papain (Worthington,
LK003176) following mechanical dissociation in complete DMEM (In-
vitrogen, 11960 – 044) containing 10% FBS (Invitrogen, 10500) and 5%
penicillin-streptomycin. Tissue was washed with DMEM and pelleted
twice before being resuspended in complete Neurobasal media (Invitro-
gen, 21103049) containing 10% B27 (Invitrogen, 17504), 5% PenStrep
and 0.25% L-gluatamine (Invitrogen, 25030). Cells were plated at a den-
sity of 2–5  10 4 cells/ml on glass coverslips that had been coated with
poly-D-lysine (Sigma, P7280) and Laminin protein (Invitrogen,
2301015). Cultures were maintained in a humidified incubator at 37°C,
5% CO2.
Transfection. Granule cells were transfected at DIV7 with pRK5-
Homer1a overexpression vector and mCherry fluorescent marker vector
(Clontech, 632523) using Lipofectamine 2000 (Thermo Fisher Scientific,
11668027); 250 ng DNA per vector was added to Optimem and then
incubated with Lipofectamine at room temperature before being dripped
onto the cultures and left to recover for 5 d before recordings were taken.
Electrophysiology
Visualized patch-clamp recordings from cultured granule cells were per-
formed using an infrared differential interference contrast imaging sys-
tem. The perfusion solution contained the following (in mM): 119 NaCl,
2.5 KCl, 1.3 Na2SO4, 2.5 CaCl2, 26.2 NaHCO3, 1 NaH2PO4, 22 glucose
and was continuously gassed with 95% O2/5% CO2, pH 7.35 (290 –298
mOsm). The intracellular pipette solution for voltage-clamp experi-
ments contained the following (in mM): 120.5 CsCl, 10 KOH-HEPES, 2
EGTA, 8 NaCl, 5 QX-314 Br  salt, 2 Na-ATP, 0.3 Na-GTP. For current-
clamp recordings, intracellular pipette solution contained the following
(in mM): 126 K-gluconate, 4 NaCl, 5 HEPES, 15 glucose, 1 K2SO4  7H2O,
2 BAPTA, 3 Na-ATP. pH was adjusted to 7.2 and osmolarity adjusted to
295 mOsm.
In experiments on DGCs, we selected for patching neurons, which
morphology reproducing that reported for mature DGCs in culture: cells
with roundish body of 10 –15 m and bipolar neurites (Lowenstein and
Arsenault, 1996). Each patched cell was first tested for electrophysiolog-
ical properties. Further experimental procedures were performed at cells
reproducing all three characteristics of mature DGCs: whole-cell capac-
itance of 15–25 pF, membrane potential of 65 to 75 mV, and input
resistance of 150 –300 M (Spampanato et al., 2012).
In experiments on CGCs, we selected for patching cells with mature
morphology reproducing that observed in our earlier study: small (5
m) neurons with short dendrites (Sylantyev et al., 2013), and then
monitored their electrophysiological properties. We continued experi-
mental protocol on cells reproducing all three of the following character-
istics: whole-cell capacitance of 2–5 pF, membrane potential 60 or 70
mV, input resistance 5– 8 G (Hevers and Lüddens, 2002; Sylantyev et
al., 2013).
Outside-out and nucleated patch recordings. Outside-out patches and
cell membrane bags containing intact nucleus and cytoplasm (nucleated
patches [NPs]) were pulled from DGCs and CGCs, and recordings were
performed in voltage-clamp mode (Vhold  70 mV). Solution exchange
experiments were performed as described in our previously published
protocol (Sylantyev and Rusakov, 2013). Briefly, we used a -glass appli-
cation pipette with 200-m-tip diameter attached to the micromanip-
ulator. The position of the pipette was controlled by piezoelectric
element (the speed of switch was 50 –100 s). One pipette channel was
filled with the bath aCSF solution; another channel had glutamate recep-
tor ligands. Pressure was regulated by a PDES-02DX pneumatic micro
ejector (npi) using compressed nitrogen separately in each of two chan-
nels. Solutions with NMDA  glycine, NMDA  glycine  DHPG, and
NMDA  glycine  FTIDC  Fenobam were exchanged in a pipette
channel (7–12 s) during the exposure of nucleated patch to the bath
solution channel.
Whole-cell recordings. Whole-cell EPSPs were measured in current-
clamp mode in the presence of the following set of ligands: picrotoxin (50
M), NBQX (20 M), strychnine (1 M), and CGP-55845 (1 M). Re-
cordings were performed at 32°C–34°C; the patch pipette resistance was
3–7 M, depending on particular experimental conditions. Series resis-
tance was monitored throughout experiments using a 5 mV step com-
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mand; cells with unstable series resistance (25 M) or unstable holding
current were rejected.
To assess modulation of synaptic efficacy in polysynaptic signaling
pathways, we used an experimental approach tested on hippocampal cell
cultures earlier (Bi and Poo, 1999). Briefly, evoked EPSCs were recorded
from the neuron in a network of 20 –30 cells (cut from surrounding cell
culture by blunt electrode) after current injection applied to another
patched neuron nearby. For the sake of clarity, we isolated segments of
neuronal networks containing only one Homer1a-overexpressing cell,
which was recorded when disruption of Homer interlink was studied; or
no Homer1a-overexpressing cells when we studied G-protein-delivered
crosstalk. Perfusion solution in this experiment did not contain receptor
antagonists. Each EPSC component propagated by recorded neuron was
interpreted as a signal delivered through separate polysynaptic pathway
with a specific transmission delay. To quantify the impact of mGluRI-
NMDAR crosstalk on synaptic efficacy, we measured probability of EPSC
component occurrence ( P) in control and after series of paired stimuli,
when G-protein signaling cascade and/or Homer protein interlink were
interrupted. To allow registration of both increase and decrease of P, in
the beginning of the experiment, stimulation was adjusted to generate P
in an interval 25%  P  75%. If under control conditions EPSC com-
ponent had P out of this interval, the component was not used in further
statistical calculations.
Fluorescent imaging and immunostaining
DIV11–14 mCherry-positive cells were selected for tests of Homer1a-
overexpression effects using induced fluorescence (em 580 nm). An
experimental test of calbindin-D28k presence was done with a method
described previously (Müller et al., 2005). To do this, whole-cell patch
clamp was performed with the GFP added to intracellular solution. After
patching and recording of electrophysiological parameters (membrane
potential, membrane capacitance, input resistance), patching pipette was
withdrawn and a fluorescent image of the patched cell taken (em 510
nm). Hereupon coverslips were placed to 4% PFA for 12 h at room
temperature and then incubated at 4°C for 24 h with monoclonal mouse
anti-calbindin-D28k antibodies (1:1000) in TBS with 0.3% Triton X-100.
Next, biotin-conjugated sheep anti-mouse antibodies (1:200) and
streptavidin-conjugated Cy5 (1:300) were applied sequentially over-
night; then Cy5 fluorescence imaged (em 670 nm).
Acquisition and analysis
Recordings were obtained using a MultiClamp 700B amplifier (Molecu-
lar Devices), filtered at 4 – 8 kHz, digitized at 10 kHz, and stored on a PC.
pClamp/Clampfit 10x software (Molecular Devices) was used for data
storage and off-line analysis.
Analysis of the macroscopic currents. Activation of NMDARs with high
concentrations of NMDA and glycine (50 M each) at outside-out and
nucleated patches evoked macroscopic responses, where “peak response”
was obtained as a difference between baseline (average for 50 ms before
application of NMDAR ligands) and maximum evoked current; “stable”
or “equilibrated” response was obtained as a difference between baseline
and stable current generated at 200 – 800 ms interval 4 s after start of
continuous application of NMDAR ligands.
Analysis of the single-channel recordings. Activation of NMDARs with
low concentration of NMDA and glycine (1 M each) at outside-out and
nucleated patches evoked single-channel openings to three conductance
levels: 51.9 	 7.8 pS, 37.2 	 6.4 pS, and 22.1 	 8.3 pS. The larger
conductance level contributed 91.9% of the single-channel current,
whereas medium and low subconductance levels contributed 6.2% and
1.9% of the current, respectively; thus, the larger main conductance level
was used when (possible) changes of single-channel conductance were
compared under different experimental conditions. Because it was virtu-
ally impossible to determine accurately the number of channels in a
nucleated patch, the open probability was obtained as the total open
probability of N channels (NPo), calculated as the proportion of the
channel total open time to the duration of recording. Because NPo in
individual patches widely varied (from 0.02 to 0.2), for statistical calcu-
lations we used values normalized to control (NPo generated by
NMDAGly in corresponding patch). With the low (1 M) NMDA and
glycine concentrations used in this study, the majority of channel events
were single-level events. In a case where there were multiple levels of channel
openings, only levels with the highest conductance was analyzed. This pre-
vented us from overestimation of NPo increase because in multichannel
patch increased NPo would be accompanied by increase of proportion of
multilevel events. To inspect the stationarity of channel activities, conduc-
tance, NPo, and the open time were followed in control experiments for up to
15 min; no time-dependent alterations were detected.
Strychnine, FTIDC, Fenobam, GGP-55845, NBQX, APV, and PeTX were
purchased from Tocris Bioscience. All other chemicals, biotin-conjugated
sheep anti-mouse antibodies, and monoclonal anti-calbindin-D28k mouse
antibodies were purchased form Sigma-Aldrich. Streptavidin-conjugated
Cy5 and GFP were purchased from Thermo Fisher Scientific.
All data are given as mean 	 SEM. Statistical comparisons were made
with Student’s unpaired t test, unless difference is indicated in the text;
p  0.05 was taken as a threshold of significance.
Figures 9E and 10 were created with elements from PPT Neuroscience
Toolkit 2010 (Motifolio).
Results
mGluRIs modulate equilibrated NMDAR response
First, we tested the mGluRI-NMDAR interaction on nucleated
membrane patches where solutions containing mGluRI and
NMDAR ligands were exchanged on the same patch, with regis-
tration of stable response amplitude. Three combinations of li-
gands were applied at the same patch sequentially: first, 50 M
NMDA  50 M glycine (Gly) to activate only NMDARs; second,
50 M NMDA  50 M Gly  50 M DHPG to activate NMDARs
and mGluRIs; being compared with response generated by
NMDARs only, this should reveal mGluRIs modulatory effect on
NMDARs; third, 50 M NMDA  50 M Gly  inverse agonists
of mGluRIs: 100 nM FTIDC and 1 M Fenobam (FB); compari-
son to “NMDARs only” response should reveal whether mGluRIs
modulate NMDARs due to spontaneous activation. Each solu-
tion was applied for 4 s, as this time was enough to stabilize
NMDAR response amplitude. This protocol was repeated on
intact cells and cells overexpressing Homer1a with standard
intracellular solution and intracellular solution containing
PeTX (1 g/ml), which allowed us to register four modes of
mGluRI-NMDAR crosstalk: mode i, intact cell, standard in-
ternal solution: both Homer- and G-protein signaling path-
ways are active; mode ii, intact cell, internal solution with
PeTX: only Homer signaling pathway is active; mode iii,
Homer1a-overexpressing cell, standard internal solution: only
G-protein signaling pathway is active; mode iv, Homer1a-
overexpressing cell, internal solution with PeTX: both signal-
ing pathways are blocked. To account for individual patch
characteristics, for statistical calculations, the response ampli-
tudes were normalized to the amplitude of response generated
by the application of 50 M NMDA  50 M Gly.
Nucleated patches from DGCs, subjected to this experimental
protocol, demonstrated a significant impact of mGluRIs on
NMDAR function delivered through both Homer- and G-protein
signaling chains. In contrast, the application of mGluRI in-
verse agonists, as in all further experiments, did not cause any
significant modulation of effect generated by NMDAGly
(Fig. 1). Normalized response amplitude: mode i, 1.29 	 0.094
when mGluRIs were activated by DHPG versus 0.95 	 0.155
when mGluRIs were blocked by FTIDCFB; mode ii, 1.19 	
0.068 versus 1.03 	 0.12; mode iii, 1.66 	 0.13 versus 1.02 	 0.1;
mode iv, 1.04 	 0.11 versus 1.01 	 0.13. Significance of differ-
ence from unity, when mGluRIs were activated: mode i, p 

0.036, n 
 9; mode ii, p 
 0.034, n 
 6; mode iii, p 
 0.004 (n 

6, paired Student’s t test). The normalized mGluRI-modulated
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response in mode iii was also significantly higher than that of
mode i: 1.66 	 0.13 versus 1.3 	 0.094, p 
 0.044 (n 
 6, Stu-
dent’s t test; Fig. 1C).
When a similar experiment was repeated on nucleated
patches from CGCs (Fig. 2), only G-protein signaling path-
way, being activated alone (mode iii), generated a significant
modulatory (downregulatory) effect. Normalized response
amplitude: mode i, 1.06 	 0.07 when mGluRIs were activated
versus 0.92 	 0.07 when mGluRIs were blocked; mode ii,
1.11 	 0.08 versus 1.05 	 0.06; mode iii, 0.66 	 0.05 versus
Figure 1. mGluRIs potentiate amplitude of equilibrated NMDAR response through G-protein and Homer signaling pathways in DGCs. A, Nucleated patches excised from control cell. Left, Standard
intracellular solution (both signaling pathways are active). Right, PeTX added to intracellular solution (only Homer pathway active). B, Nucleated patch excised from the Homer1a-overexpressing cell. Left,
Standard intracellular solution (only G-protein signaling pathway active). Right, PeTX added to intracellular solution (both signaling pathways are blocked). Color codes of applied ligand cocktails and scale bars
apply to A and B. Dashed line indicates time interval where response amplitude was calculated. C, Statistical summary of A and B. Response amplitudes are normalized to amplitude generated by NMDAGly.
Significance of difference from unity: *p  0.05; **p  0.01; Student’s t test. Inset, Fluorescent image of cultured DGC cotransfected with Homer1a and mCherry.
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0.96 	 0.08; mode iv, 1.00 	 0.09 versus 0.97 	 0.07. Signif-
icance of difference from unity when mGluRIs were activated
for mode iii: p 
 0.016 (n 
 6, paired Student’s t test); in all
other cases, no significant difference was observed (Fig. 2C).
As a control, we tested this experimental protocol on
outside-out patches excised from DGCs and CGCs, where
both Homer- and G-protein signaling chains were supposed
to be destroyed. As expected, in this experiment, any kind of
Figure 2. mGluRIs downregulate amplitude of equilibrated NMDAR response through G-protein signaling pathway in CGCs. A, Nucleated patch excised from control cell. Left, Standard
intracellular solution. Right, PeTX added to intracellular solution. B, Nucleated patch excised from the Homer1a-overexpressing cell. Left, Standard intracellular solution. Right, PeTX added to
intracellular solution. Color codes of applied ligand cocktails and scale bars apply to A and B. C, Statistical summary of A and B. Response amplitudes are normalized to amplitude generated by
NMDAGly. Significance of difference from unity: **p  0.01; paired Student’s t test. Inset, Fluorescent image of cultured CGC cotransfected with Homer1a and mCherry.
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pharmacological manipulations did not exert any significant
effect (Fig. 3).
mGluRIs modulate single-channel opening probability
of NMDARs
After studying mGluRIs’ impact on macroscopic NMDAR
response, we asked how mGluRIs modulate the functional
characteristics of individual NMDAR ion channels. To clarify
this, we repeated the same experimental protocol, but with
lowered concentrations of NMDA (1 M) and Gly (1 M) to
make single-channel openings visible. Channel conduct-
ance, average open time, and opening probability were used
as quantitative characteristics of the effect of mGluRIs
(Fig. 4).
Figure 3. mGluRI-NMDAR crosstalk is absent in outside-out patches. A–D, Example traces from experimental protocols where significant mGluRI effect was observed in nucleated patches (see
Figs. 1C, 2C). A, Outside-out patch from intact DGC, standard intracellular solution. B, Outside-out patch from intact DGC, internal solution with PeTX. C, Outside-out patch from DGC overexpressing
Homer1a, standard internal solution. D, Outside-out patch from intact CGC, internal solution with PeTX. Scale bars and color codes apply to A–D. E, Statistical summary on normalized response
amplitudes for i, ii, iii, and iv experimental modes in DGCs and CGCs. Amplitudes normalized to the value generated by NMDAGly.
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In DGCs, the average open time (13.7 	 2.6 ms) and single-
channel conductance (52.1 	 2.4 pS) were indistinguishable be-
tween recordings in modes i–iv (Fig. 4C). However, data on
opening probability demonstrated a significant upregulation of
NMDAR function in i–iii modes, when normalized to control:
mode i, 1.52 	 0.13 when mGluRIs were activated versus 1.12 	
0.11 when mGluRIs were blocked; mode ii, 1.26 	 0.1 versus
1.03 	 0.03; mode iii, 1.65 	 0.2 versus 1.06 	 0.11; mode iv,
1.01 	 0.07 versus 0.95 	 0.15. Significance of difference from
unity when mGluRIs were activated for modes i–iii: p 
 0.002,
p 
 0.029, and p 
 0.013, respectively (n 
 6 for all cases, Stu-
dent’s t test). In mode iv, no significant difference from unity was
observed (Fig. 4C).
In CGCs, similar to DGCs, the disruption of G-protein- and
Homer-containing mGluRI-NMDAR crosstalk did not result in
significant changes of average open time (11.9 	 3.2 ms) and
single-channel conductance (51.6 	 3.7 pS) (Fig. 5). However, in
CGCs, experimental modes ii and iii showed a significant
mGluRIs effect on opening probability (Fig. 5C): mode i, 1.1 	
0.15 when mGluRIs were activated versus 1.07 	 0.1 when
mGluRIs were blocked; mode ii, 1.31 	 0.18 versus 1.23 	 0.19;
mode iii, 0.83 	 0.06 versus 0.93 	 0.1; mode iv, 0.93 	 0.06
versus 0.96 	 0.12. Significance of difference from unity when
mGluRIs were activated for modes ii and iii: p 
 0.042 and p 

0.037, respectively (n 
 6 for both cases, Student’s t test).
Rapid potentiation of NMDAR effect is delivered exclusively
through Homer-containing interlink
After experiments on long intervals, where Homer- and G-protein-
delivered effects overlapped, we tested mGluRI-NMDAR modu-
lation at short intervals (units of milliseconds). We presumed
that, under these conditions, the G-protein-delivered effects
might not have enough time to fully develop, as was observed
previously (Sylantyev et al., 2013).
We found in both DGCs and CGCs, after rapid (1 ms) ap-
plication of agonists, that the activation of mGluRIs has increased
Figure 4. mGluRIs modulate NMDAR opening probability in DGCs. A, Control cell. B, Homer1a-overexpressing cell. A, B, Left, Standard intracellular solution. Right, PeTX added to intracellular
solution. Top to bottom, NMDAGly, NMDAGlyDHPG, NMDAGlyFTIDCFB. Scale bars apply to A and B. C, Statistical summary on single-channel functional parameters for A and B.
Significance of difference from unity: *p  0.05; **p  0.01; Student’s t test.
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peak amplitudes of NMDAR response independently of PeTX
presence in the internal solution. For DGCs (Fig. 6): mode i,
DHPG in applied solution increased the response amplitude by
16.09 	 1.48% versus 0.68 	 1.75% when the applied solution
contained FTIDCFB; mode ii, 12.52 	 1.42% versus 0.1 	
1.74%. For modes i and ii, significance of difference from zero
when mGluRIs were activated: p 
 0.003 and p 
 0.004, respec-
tively (n 
 6). However, Homer1a overexpression prevented
such a potentiation: mode iii, 3.68 	 2.01% versus 1.87 	 2.54%;
mode iv, 1.54 	 1.94% vs 0.02 	 1.66% (p  0.05 for both
cases, n 
 6; Fig. 6C). The same experiment on CGCs (Fig. 7):
mode i, 9.88 	 1.5% versus 3.2 	 2.18%; mode ii, 9.57 	 1.93%
versus 0.97 	 2.78%; mode iii, 2.15 	 2.49% versus 1.76 	
1.77%; mode iv, 1.97 	 2.15% versus 2.3 	 2.12%. Significance
of difference from zero when mGluRIs were activated in intact
cells: modes i and ii, p 
 0.006 and p 
 0.008, respectively (n 

6 for both cases, paired Student’s t test; Fig. 7C). In all record-
ings, the maximum potentiation effect of mGluRIs developed
within the 5 ms time window after the application of ligands
(Figs. 6, 7).
mGluRIs modulate NMDAR-generated action potentials
(APs) via both Homer- and G-protein signaling pathway
Next, we asked whether and to what extent Homer- and G-protein-
mediated mGluRI-NMDAR signaling pathways regulate the gener-
ation of neuronal APs. To clarify this, we performed whole-cell
recordings from neurons in dispersed cell culture, where APs were
evoked by consequent 300 ms applications of the same set of
solutions, as in the experiments on membrane patches (Fig. 8).
To quantify mGluRI input into AP generation, we used action
potential ratio (APR) obtained as a number of APs evoked
when NMDARs and mGluRIs are activated with DHPG
NMDAGly or mGluRIs are suppressed with NMDAGly
FTIDCFB, divided by number of APs generated in the same
cell by NMDAGly only.
Here we found that in DGCs blocking of each signaling path-
way leads to a significant reduction of APR compared with con-
trol value: mode i, control, 1.82 	 0.19 when mGluRIs were
activated versus 1.08 	 0.14 when mGluRIs were blocked; mode
ii, 1.32 	 0.1 versus 1.04 	 0.13; mode iii, 1.52 	 0.09 versus
1.1 	 0.11; mode iv, 1.17 	 0.18 versus 1.02 	 0.12. Significance
Figure 5. mGluRIs modulate NMDAR opening probability in CGCs. A, Control cell. B, Homer1a-overexpressing cell. A, B, Left, Standard intracellular solution. Right, PeTX added to intracellular
solution. Top to bottom: NMDAGly, NMDAGlyDHPG, NMDAGlyFTIDCFB. Scale bars apply to A and B. C, Statistical summary on single-channel functional parameters for A and B.
Significance of difference from unity: *p  0.05; Student’s t test.
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of difference from control when mGluRIs were activated in
modes ii–iv: p 
 0.044, p 
 0.047, and p 
 0.032, respectively
(n 
 6 for all three comparisons, paired Student’s t test). When
Homer- and G-protein pathways were blocked simultane-
ously in mode iv, the firing frequency observed with DHPG
and FTIDCFB in the applied solution became indistinguish-
able from unity (i.e., from that generated by NMDAGly
only): p 
 0.144 and p 
 0.426 for DHPG and FTIDCFB,
Figure 6. mGluRIs potentiate rapid NMDAR response through Homer signaling pathway only; nucleated patches excised from DGCs. A, Control cell. Left, Standard intracellular solution. Right,
PeTX added to intracellular solution. B, Homer1a-overexpressing cell. Left, Standard intracellular solution. Right, PeTX added to intracellular solution. Color codes of applied ligand cocktails and scale
bars apply to A and B. Each trace is an average of 3–5. Inset, Illustration of rapid solution application system (schematic) with -glass pipette, which applies two different solutions at nucleated patch
placed at a patch pipette. Numbers denote sequence of drug mixture replacements in -glass pipette channels: 1, NMDAGly ¡ NMDAGlyDHPG; 2, NMDAGlyDHPG ¡
NMDAGlyFTIDCFB. During solution replacement time periods, patch was exposed to solution flowing from “bottom” channel. C, Statistical summary on response amplitudes in A and B.
Significance of difference from zero: **p  0.01; Student’s t test.
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respectively (n 
 6, paired Student’s t test for both APR com-
parisons; Fig. 8E).
In contrast, in CGCs, only Homer1a overexpression triggered
significant mGluRI-mediated modulatory effects on APR com-
pared with control: mode i, control, 1.15 	 0.17 when mGluRIs
were activated versus 0.92 	 0.13 when mGluRIs were blocked;
mode ii, 1.47 	 0.14 versus 1.08 	 0.12; mode iii, 0.81 	 0.08
versus 0.95 	 0.14; mode iv, 1.05 	 0.11 versus 1.16 	 0.14. APR
in mode iii was significantly lower compared with control and to
unity: p 
 0.042 and p 
 0.021, respectively (n 
 8 for both
comparisons, paired Student’s t test). As in DGCs, under mode
iv, APR generated with DHPG and FTIDCFB was indistin-
guishable from unity: p 
 0.35 and p 
 0.08, respectively (n 
 6,
paired Student’s t test for both comparisons; Fig. 8F).
Figure 7. mGluRIs potentiate rapid NMDAR response through Homer signaling pathway only; nucleated patches excised from CGCs. A, Control cell. Left, Standard intracellular solution. Right,
PeTX added to intracellular solution. B, Homer1a-overexpressing cell. Left, Standard intracellular solution. Right, PeTX added to intracellular solution. Color codes of applied ligand cocktails and scale
bars apply to A and B. Each trace is an average of 3–5. C, Statistical summary on response amplitudes in A and B. Significance of difference from zero: **p  0.01; Student’s t test.
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mGluRI-NMDAR crosstalk modulates synaptic plasticity
As the next step, we set out to clarify the role of two types of
mGluRI-NMDAR crosstalk in synaptic transmission and induc-
tion of synaptic plasticity. To comprehend this, we used networks
of cultured neurons where two polysynaptically connected cells
were patched simultaneously. Current injection into one cell
(held in current-clamp mode) generated AP with the subsequent
poly-component EPSCs recorded from another cell (held in
voltage-clamp mode). We interpreted each EPSC component as a
signal through separate transmission pathway with specific delay.
Under the low-frequency stimulation (1 current injection per
15 s), the probability of occurrence (P) remained stable for each
EPSC component observed in recorded cell. We thus used the
EPSC profile as a tool for quantitative measurement of synaptic
efficacy (for more details, see Materials and Methods). To exam-
ine synaptic plasticity in recorded network, we applied a train of
50 paired-pulse stimuli with 50 ms interpulse interval at 1 Hz.
After that, we monitored changes in P (decrease or increase, i.e.,
P) of preexisting EPSC components, which reflect remodeling
of signaling pathways (Fig. 9A,B). Recorded neurons held in
modes i–iv allowed assessment of the input of two types of
mGluRI-NMDAR crosstalk into modulation of synaptic plasticity.
We found, in DGCs, that blocking of each mGluRI-NMDAR
crosstalk pathway induces a significant lowering of P: mode i,
control: 0.24 	 0.023 when mGluRIs were activated versus
0.15 	 0.019 when mGluRIs were blocked; mode ii: 0.17 	 0.022
versus 0.12 	 0.015; mode iii: 0.16 	 0.017 versus 0.1 	 0.013;
mode iv: 0.14 	 0.021 versus 0.13 	 0.018. Significance of differ-
ence from control for modes ii–iv: p 
 0.038, p 
 0.022, and p 

0.034, respectively (n 
 7, Student’s t test). In modes i—iii, block
Figure 8. G-protein- and Homer-mediated signaling chains control AP generation via NMDARs. A–D, Example recordings where AP ratio was shifted significantly from values generated by
NMDAGly. Top, APs evoked by 300 ms application of NMDA 50 M  Gly 50 M. Bottom, APs evoked by application of NMDA 50 M  Gly 50 M  DHPG 100 M. A, Intact DGC, PeTX 1 g/ml
in internal solution. B, Homer1a-overexpressing DGC. C, Homer1a-overexpressing DGC, PeTX in internal solution. D, Homer1a-overexpressing CGC. Scale bars apply to A–D. E, Statistical summary
for DGCs. Ratios of AP number generated by DHPGNMDAGly to that generated by NMDAGly. F, Same as in E, but for CGCs. Color codes apply to E and F. Inset, Illustration of solution application
system (schematic) with -glass pipette, which applies solution with mGluRI and NMDAR ligands (“top” channel) at a patched neural cell. During replacement NMDAGly¡NMDAGlyDHPG
in “top” channel, patched cell was exposed to perfusion solution flowing from “bottom” channel. Significant difference from control (no PeTX added, no Homer1a overexpression): *p  0.05;
Student’s t test. n 
 6 – 8.
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Figure 9. mGluRI-NMDAR crosstalk and synaptic plasticity in cultured hippocampal neurons. A, B, Twenty consecutive EPSCs (inward currents are shown upward) recorded from a cultured neuron
in response to stimulation of a nearby neuron before (A) and after repetitive paired-pulse stimulation (B). There is an increase of second and third EPSC component numbers after paired-pulse
stimulation. Scale bars: A, B, 20 ms. C, D, Statistical summary of pathway remodeling induced by paired-pulse stimulation with modulatory impact of mGluRIs (C) and NMDARs (D). Asterisks above
“mGluRIs blocked” and “NMDARs blocked” bars indicate significance of difference between responses obtained with blocked mGluRIs or NMDARs, and when both receptor species are active, under
the same experimental mode: *p  0.05; **p  0.01; Student’s paired t test. E, Three hypothetical polysynaptic pathways (dashed lines 1–3) leading from stimulated neuron (S) to the recorded
neuron (R) with different transmission delays corresponding to the onset latencies of the three distinct EPSC components. F, Image series illustrating selection of DGCs for further experimental work.
Left column, Dispersed culture, solitary DGC with developed morphology (for details, see Materials and Methods). Right column, Dense culture, group of differentiated DGCs. Top to bottom, Images
under infra-red DIC; GFP fluorescence (em 510 nm) after whole-cell patching; Cy5 fluorescence (em 670 nm) after immunostaining for calbindin-D28k; overlap of GFP and Cy5 fluorescence patterns.
Arrows indicate cell soma. Arrowheads indicate main neurite(s). Scale bar: both columns. G, Statistical summary on electrophysiological properties of DGCs recorded in F; n 
 6.
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of mGluRIs caused significant reduction of P compared with
readout when mGluRIs were active in the same mode: p 
 0.021,
p 
 0.031, and p 
 0.036, respectively (n 
 7, Student’s t test for
all three comparisons; Fig. 9C).
In turn, in CGCs blocking of Homer pathway (mode iii) did
not trigger significant change of P compared with control, un-
like the block of G-proteins chains (mode ii) and of both signal-
ing pathways (mode iv): mode i, control: 0.26 	 0.013 when
mGluRIs were activated versus 0.18 	 0.03 when mGluRIs were
blocked; mode ii: 0.19 	 0.011 versus 0.14 	 0.013; mode iii:
0.21 	 0.013 versus 0.16 	 0.02; mode iv: 0.12 	 0.022 versus
0.12 	 0.02. For comparisons of modes ii and iv: to control
when mGluRIs activated ( p 
 0.0102 and 0.011, respectively,
n 
 8, Student’s t test). As in DGCs, in modes i–iii, block of
mGluRIs caused significant reduction of P compared with
readout when mGluRIs were active: p 
 0.018, p 
 0.045, and
p 
 0.019, respectively (n 
 8, Student’s t test for all three
comparisons; Fig. 9C).
For both DGCs and CGCs, we did not observe significant
difference of P values obtained when mGluRIs were blocked
under any experimental mode (i–iv), from P obtained when
mGluRIs were activated, but both mGluRI-NMDAR signaling
pathways were blocked (iv): p  0.05 for all comparisons, n 
 7
(DGCs) and n 
 8 (CGCs), Student’s t test (Fig. 9C).
As a general rule, alterations of postsynaptic current profile
displayed changes in P of particular components, but without
substantial variation of their amplitude. In DGCs under mode i,
amplitude of the first peak after the stimulation train was
changed by 17 	 22% compared with pretrain value; under mode
ii, by 11 	 19%; under mode iii, by 21 	 18%; under mode iv,
by 7 	 16% (p  0.3 for all comparisons to pretrain value, n 
 7,
Student’s t test). In CGCs under mode i, first peak amplitude was
changed by 14 	 9%; under mode ii, by 8 	 13%; under mode
iii, by 4 	 11%; under mode iv, by 9 	 8% (p  0.2 for all
comparisons to pretrain values, n 
 8, Student’s t test).
Next, to quantify the role of NMDARs in synaptic plasticity
and signaling pathway remodeling, we repeated the same exper-
imental protocol, but with pharmacological block of NMDARs
(with 50 M APV) rather than of mGluRIs. We found that phar-
macological silencing of NMDARs induces a significant decrease
of P values (i.e., much fewer changes of EPSC profiles were
observed under all experimental modes; Fig. 9D). For DGCs,
mode i: 0.075 	 0.023 when NMDARs were blocked versus
0.23 	 0.033 when NMDARs were active; mode ii: 0.067 	 0.018
versus 0.16 	 0.039; mode iii: 0.049 	 0.02 versus 0.18 	 0.022;
mode iv: 0.035 	 0.014 versus 0.11 	 0.014. For comparisons
“APV-active NMDARs”: p 
 0.0032, p 
 0.0067, p 
 0.0054, and
p 
 0.0086 for modes i–iv, respectively (n 
 7, Student’s t test).
For CGCs, mode i: 0.058 	 0.02 when NMDARs were blocked
versus 0.24 	 0.42 when NMDARs were active; mode ii: 0.61 	
0.022 versus 0.17 	 0.021; mode iii: 0.048 	 0.011 versus 0.15 	
0.019; mode iv: 0.046 	 0.011 versus 0.09 	 0.024. For compar-
isons “APV- active NMDARs”: p 
 0.0028, p 
 0.0073, p 

0.0062, and p 
 0.023 for modes i–iv, respectively (n 
 7, Stu-
dent’s paired t test).
Finally, as an additional control, we tested accuracy of our cell
selection algorithm on DGCs (Fig. 9F,G). To do this, we patched
cultured cells, preselected on visual criteria, with pipette solution
containing GFP. If cell electrophysiological parameters were in
predefined intervals (membrane capacitance 15–25 pF, mem-
brane potential 65 to 75 mV, input resistance 150 –300 M), we
performed an accurate withdrawal of patch pipette and captured
an image of GFP fluorescence. Afterward, the coverslip with
cell culture underwent immunostaining with Cy5 fluorescent
dye for the protein calbindin-D28k, which is a characteristic
DGC marker (Müller et al., 2005) (for more details, see Mate-
rials and Methods).
All six cells, which reproduced predefined electrophysiologi-
cal parameters, have also demonstrated Cy5 fluorescence, thus
confirming that chosen selection algorithm circumscribes at least
a part of the DGC population. Electrophysiological readouts in
this experiment were as follows: membrane capacitance, 21.61 	
2.77 pF; membrane potential, 68.25 	 3.12 mV; input resistance,
271.92 	 9.33 M.
Discussion
In this work, we examined the mGluRI-NMDAR crosstalk
through two pathways: G-protein-mediated and Homer-
mediated (Fig. 10). At a short time interval (units of millisec-
onds), the only significant result of such a crosstalk, similar for
DGCs and CGCs, was a facilitation of NMDAR response trig-
gered by mGluRIs and delivered through Homer-containing
scaffold. On a long time interval (from hundreds of milliseconds
to seconds), this facilitation overlaps with slower modulatory
impact delivered through G-protein-initiated signaling cascade.
The type of G-protein-delivered impact (facilitation or depres-
sion) depends on the particular cell type. The end result of
mGluRI-NMDAR crosstalk is therefore cell-specific and depends
on a registration timescale.
In DGCs, the mGluRIs generated a significant potentiation of
long, equilibrated NMDAR response under control conditions
(Fig. 1) in line with previous reports (Awad et al., 2000). The
potentiation generated by mGluRIs in Homer1a-overexpressing
DGCs (i.e., delivered through G-protein pathway only) was sig-
nificantly higher than that delivered via both G-protein and
Homer pathways in intact cells (Fig. 1C). This implies the com-
petitive nature of the two, albeit unidirectional, signals. In con-
trast, in CGCs, only the G-protein pathway, being activated alone
in Homer1a-overexpressing cells, induced a significant down-
regulation of NMDAR effect, thus resembling previous observa-
tions (Bertaso et al., 2010). No significant effect of any direction
was generated by the Homer pathway only or when both path-
ways were active (Fig. 2). The plausible explanation is that the
readout of the Homer-delivered effect on equilibrated response
in CGCs is below the applied method’s sensitivity, but this path-
way functionally prevails over G-protein signaling and thus muf-
fles the downregulation delivered through G-proteins.
For both DGCs and CGCs, no significant effect of mGluRIs
was demonstrated when Homer- and G-protein-controlled path-
ways were simultaneously blocked (Figs. 1C, 2C), which implies
the lack of significant input from other mechanisms of mGluRI-
NMDAR crosstalk. Next, we observed the effect of DHPG in
nucleated patches (Figs. 1, 2, 4 –7) and in whole-cell (Figs. 8, 9),
but not in outside-out patches (Fig. 3). This proves the critical
dependence of mGluRI-NMDAR interaction from cytoplasmic
elements and/or elements not anchored into outer cell mem-
brane. On top of that, the lack of DHPG effect in outside-out
patches proves that DHPG does not activate NMDARs directly,
acting as NMDA coagonist (Contractor et al., 1998).
An alternative pathway of mGluRI-NMDAR crosstalk is mod-
ulation of assembly of Homer-containing protein scaffold, where
repetitive NMDAR activation shifts equilibrium to disassembled
state (Moutin et al., 2012) (Fig. 10). Can this pathway be involved
into modulation of effects studied in our research? Moutin et al.
(2012) demonstrated localization of such a process exclusively in
postsynaptic compartments; thus, it could exert an effect in
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whole-cell experiment (Fig. 9). In contrast, axo-somatic synapses
were reported for DGCs (Toni et al., 2007); however, to the best
of our knowledge, not for CGCs. Therefore, similar results of
Homer-delivered rapid effects obtained after repetitive NMDAR
activation on NPs pulled from both DGCs and CGCs (Figs. 6, 7)
argue against the presence of NMDAR-induced disruption of
Homer-containing interlink at least in this type of experiment.
In contrast to the equilibrated NMDAR response (Figs. 1, 2),
where the effect of mGluRIs was specific to the cell type under
study (potentiation of NMDAR response in DGCs, suppression
in CGCs), at a short time interval after rapid ligand application,
the mGluRIs potentiate an NMDAR response amplitude in both
cell types (Figs. 6, 7), resembling short-term mGluRI effects,
which have been documented previously (Kinney and Slater,
1993; Rossi et al., 1996; Sylantyev et al., 2013). This potentiation is
insensitive to PeTX but does not develop in Homer1a-
overexpressing cells, thus suggesting the Homer protein chain as
the only underlying mechanism.
Despite the apparent modulatory impact of mGluRI-NMDAR
crosstalk on neural signaling revealed in our experiments, it is still an
important question: whether our data represent a typical set of ef-
fects. Or this is a result of specific combination of experimental con-
ditions, such as the age of tested cells and extrasynaptic, rather than
synaptic, localization of recorded receptors in experiments on
membrane patches? It was reported earlier that synaptic and ex-
trasynaptic pools of NMDARs display different proportions of
NR1 and NR2 subunits (Barria, 2007), whereas different receptor
subunits interact differently with PSD-95 protein (Bassand et al.,
1999; Al-Hallaq et al., 2007), which links them to mGluRI via the
Homer-containing scaffold (Fig. 10). On top of that, expression
levels of different NMDAR subunits (Monyer et al., 1994) and
different types of Homer protein (Shiraishi et al., 2004) are age-
dependent. However, it was shown that NMDARs and Homer
proteins make functional clusters throughout all developmental
stages in both extrasynaptic and synaptic loci of cultured neurons
(Shiraishi et al., 2003). Apart from that, studies on cultured neu-
rons of different age demonstrated effects of mGluRI-Homer-
NMDAR interaction similar to our present observations. These
effects were found in CGC NPs (Sylantyev et al., 2013) (i.e., were
generated by extrasynaptic receptors) and in a whole-cell
(Bertaso et al., 2010) (i.e., were generated primarily by synaptic
receptors). Similarly, G-protein-mediated mGluRI-NMDAR
modulation was demonstrated in cultured neurons from the ear-
liest stages of their development (Hilton et al., 2006) to matura-
tion (Lea et al., 2002); such a modulation occurs both in synapses
(Kwon and Castillo, 2008) and at extrasynaptic membrane (our
data). These observations suggest that mGluRI-NMDAR signal-
ing pathways researched in our study preserve their functionality
independently from particular receptors localization and the cell
age. However, their relative input into integrated modulatory
tone may vary depending on a stage of the neuron development.
NMDARs are widely recognized to play a pivotal role in long-
term synaptic plasticity in the CNS (Malenka and Nicoll, 1993;
Paoletti et al., 2013). In our work, we demonstrated two mGluRI-
Figure 10. Schematic of mGluRI-NMDAR signaling chains: Homer-mediated (white element titles) and G-protein-mediated (black element titles). Red lightning bolts indicate specific points
where G-protein- and Homer-mediated chain were interrupted by PeTX and Homer1a, respectively. mGluRIs and NMDARs are physically connected by scaffolding proteins of postsynaptic density,
which transmit modulatory signal through scaffolding proteins in the following order: mGluRI ¡ preso1 ¡ Homer ¡ SH3 and multiple ankyrin repeat domains (Shank) ¡ guanylate-kinase-
associated protein (GKAP)¡postsynaptic density 95 (PSD-95)¡NMDAR. Glutamate-containing vesicles of presynaptic bouton, being exocytosed, release glutamate into synaptic cleft. Glutamate
binding to mGluRI and glutamate  glycine binding to NMDAR activate both receptors. Phosphorylated NMDAR allows influx of extracellular calcium ( ECCa 2) into cell; this triggers release of
intracellular calcium ( ICCa 2) from ER. Activation (phosphorylation) of mGluRI, induced by glutamate binding, triggers activation of the G-protein Gq, subsequently activating phospholipase C
(PLC). PLC initiates conversion of phosphoinositide (PI) to inositol 1,4,5-triphosphate (IP3) and subsequent activation of diacylglycerol (DAG); IP3 initiates release of intracellular Ca
2. DAG, being
combined with increased Ca 2 concentration due to NMDAR activation, causes phosphorylation of protein kinase C (PKC). PKC initiates phosphorylation of proline-rich tyrosine kinase/cell adhesion
kinase  (Pyk2/CAK), and subsequently the cellular tyrosine kinase protein (Src). In turn, SRC potentiates NMDAR. Negative feedback loop occurs after Ca 2 influxed through NMDARs activates
Ca 2-dependent protein phosphatase 2B/calcineurin (PP2B/CaN), which dephosphorylates (i.e., at least partially deactivates) mGluRIs (Matosin and Newell, 2013).
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NMDAR crosstalk pathways to be modulators of P (i.e., of
NMDAR input into changes of synaptic strength after series of
paired stimuli) (Fig. 9D). Therefore, we found that G-protein-
controlled and Homer-controlled signaling pathways between
mGluRI and NMDAR play a significant role in synaptic plasticity
and efficacy.
Our further experiment on the signaling pathway remodeling
demonstrated that NMDAR silencing with APV reduces signifi-
cantly variability of neural network synaptic transmission and
synaptic strength (P), which is consistent with earlier observa-
tions of involvement of synaptic NMDARs into long-term plas-
ticity (Bi and Poo, 1999; O’Riordan et al., 2018). However, even
when both mGluRI-NMDAR signaling pathways were blocked
(mode iv) and APV added, we did observe a certain degree of P
(Fig. 9D,E). This may reflect involvement of mGluRI- and
NMDAR-independent mechanisms, such as modification of
GABA-ergic conductance (Linden and Connor, 1995) and/or
activity-dependent modifications of neuronal excitability (Tur-
rigiano et al., 1994).
Our experiments on neural networks demonstrated that sim-
ilar pattern of stimuli can induce opposite changes along differ-
ent signaling pathways (increase or decrease of p). Modulation of
EPSC profiles without significant impact on response amplitudes
suggests that the chosen pattern of stimulation had caused vari-
ation of synaptic strength at remote synaptic connections, thus
changing the probability of a signal transmission by different
pathways connecting stimulated and recorded cell, with variable
interplay between these pathways. This type of modification is
consistent with a paradigm of distributed storage and represen-
tation of information in neural networks (Churchland and Se-
jnowski, 1992; Bliss and Collingridge, 1993).
Constitutive agonist-independent activity of G-protein-
coupled receptors was repeatedly detected in various experimen-
tal setups and may substantially impact cell functioning and
intercellular signaling (Milligan, 2003). However, the absence of
any detectable difference between mGluRI effects under control
and when mGluRI inverse agonists FTIDC and FB are applied in
all types of experiments suggests that NMDAR effects triggered
by NMDAGly alone (i.e., without activation of mGluRIs) are
not modulated by spontaneous mGluRI activity. Thus, we pre-
sume that the nonsignificant effects of mGluRI activation in in-
tact CGCs (Fig. 8F) is due to the overlap of Homer- and
G-protein-delivered signals of opposite sign, rather than the re-
sult of, for instance, the majority of mGluRIs in the active state
(due to spontaneous activation) before application of DHPG.
Therefore, in our study, we found the functional mechanism
of mGluRI-NMDAR interaction in DGCs and CGCs to be as
follows (Fig. 10): mGluRIs, when activated, modulate NMDARs
simultaneously through Homer- and G-protein-controlled path-
ways via changes of NMDAR opening probability. The Homer-
containing protein interlink delivers potentiating signal to
NMDARs in both cell types, whereas the G-protein-mediated
signal is cell-specific: it potentiates NMDAR function in DGCs
and suppresses it in CGCs. Fast Homer-transduced effect is more
prominent at short time intervals after mGluRI activation,
whereas slower developing G-protein-delivered effect has an
advantage on long-term intervals. Additionally, Homer-
mediated potentiation tone prevails over modulation deliv-
ered by G-protein cascade, although it causes smaller absolute
effect.
The hippocampus has been recognized as a key brain area in
schizophrenia development (Harrison, 2004), associated with
decreased NMDAR function (Gao et al., 2000). Here we observed
an increase of NMDAR conductivity in Homer1a-overexpressing
DGCs (Fig. 1C) due to higher mGluRI-triggered potentiation
delivered through a G-protein chain, rather than through a com-
peting Homer interlink (Figs. 1C, 4C, 8E). This suggests a plau-
sible mechanistic explanation for haloperidol and clozapine’s
anti-schizophrenia effects associated with the upregulation of
Homer1a synthesis (Polese et al., 2002).
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